NCT03237988View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

September 20, 2017

Study Completion Date

October 4, 2017

Conditions
Healthy Subjects
Interventions
DRUG

CPI-444 Capsules

100mg Capsule

DRUG

CPI-444 Tablets

100mg Tablets

Trial Locations (1)

75247

Covance Clinical Research Unit, Dallas

Sponsors
All Listed Sponsors
lead

Corvus Pharmaceuticals, Inc.

INDUSTRY

NCT03237988 - Study to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter